Kaken Pharmaceutical Co (TSE:4521) Market Cap : 円130,120 Mil (As of May. 22, 2024)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kaken Pharmaceutical Co's share price for the quarter that ended in Dec. 2023 was 円3355. Kaken Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 38 Mil. Therefore, Kaken Pharmaceutical Co's market cap for the quarter that ended in Dec. 2023 was 円127,054 Mil.

Kaken Pharmaceutical Co's quarterly market cap declined from Jun. 2023 (円134,977 Mil) to Sep. 2023 (円131,155 Mil) and declined from Sep. 2023 (円131,155 Mil) to Dec. 2023 (円127,054 Mil).

Kaken Pharmaceutical Co's annual market cap declined from Mar. 2021 (円166,110 Mil) to Mar. 2022 (円147,114 Mil) and declined from Mar. 2022 (円147,114 Mil) to Mar. 2023 (円138,462 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kaken Pharmaceutical Co's Enterprise Value for Today is 円68,646 Mil.

Kaken Pharmaceutical Co Market Cap Historical Data

The historical data trend for Kaken Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Market Cap Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Market Cap

Get a 7-Day Free Trial

199,781.54

195,753.01

166,110.26

147,113.58

138,462.37

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															145,769.97	138,462.37	134,977.39	131,155.15	127,053.51

Competitive Comparison of Kaken Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaken Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Market Cap falls into.

Kaken Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Kaken Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )	=	Share Price (A: Mar. 2023 )	*	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	円3695	*	37.4729
	=	円138,462

Kaken Pharmaceutical Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	円3355	*	37.8699
	=	円127,054

Kaken Pharmaceutical Co (TSE:4521) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Kaken Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines